REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 | |
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |
SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
Large accelerated filer | ☐ | ☒ | ||
Accelerated filer | ☐ | Emerging growth company |
U.S. GAAP | ☐ | Accounting Standards Board | ☒ | Other | ☐ |
Property Name | Sq Ft | City | Occupancy Type | Lease end Date |
155 Bishopsgate, London EC2M 3TQ, level 2 | 10,050 | London | Leased | August 11, 2028 |
155 Bishopsgate, London EC2M 3TQ, level 3 | 20,857 | London | Leased | October 30, 2035 |
155 Bishopsgate, London EC2M 3TQ, level 4 | 16,813 | London | Leased | October 30, 2035 |
155 Bishopsgate, London EC2M 3TQ, level 5 | 37,355 | London | Leased | October 30, 2035 |
155 Bishopsgate, London EC2M 3TQ, level 8 | 19,084 | London | Leased | August 1, 2025 |
42 Rue Washington and 29 Rue de Berri, Floors 1 & 5, 1st & 4th Basement | 21,273 | Paris | Leased | January 10, 2033 |
222 W. Adams St, Suite 450, Chicago, Illinois 60606 | 21,580 | Chicago | Leased | December 31, 2029 |
140 E 45th St 10th & 11th Floor, 2 Grand Central Tower, New York 10017 | 25,058 | New York | Leased | July 31, 2030 |
Year Ended December 31, | ||
2024 | 2023 | |
(m) | ||
$ | $ | |
Consolidated income statement | ||
Commission and fee income ............................................................................................... | 1,618.1 | 1,342.4 |
Commission and fee expense ............................................................................................. | (762.0) | (637.5) |
Net commission income ................................................................................................... | 856.1 | 704.9 |
Net trading income ............................................................................................................. | 492.4 | 411.4 |
Interest income ...................................................................................................................... | 765.2 | 591.8 |
Interest expense .................................................................................................................... | (538.1) | (470.2) |
Net interest income ............................................................................................................ | 227.1 | 121.6 |
Net physical commodities income ................................................................................. | 19.1 | 6.7 |
Revenue ............................................................................................................................ | 1,594.7 | 1,244.6 |
Expenses: | ||
Compensation and benefits ............................................................................................ | (971.1) | (770.3) |
Depreciation and amortisation ....................................................................................... | (29.5) | (27.1) |
Other expenses ................................................................................................................ | (306.3) | (237.4) |
Impairment of goodwill ..................................................................................................... | — | (10.7) |
Provision for credit losses ............................................................................................... | 1.7 | (7.1) |
Bargain purchase gain on acquisitions .............................................................................. | — | 0.3 |
Other income ......................................................................................................................... | 6.3 | 3.4 |
Share of results in associates and joint ventures ............................................................ | — | 0.8 |
Profit before tax ................................................................................................................... | 295.8 | 196.5 |
Tax ...................................................................................................................................... | (77.8) | (55.2) |
Profit after tax ...................................................................................................................... | 218.0 | 141.3 |
Years Ended December 31, | ||
2024 | 2023 | |
(m) | ||
Revenue | $ | $ |
Clearing ........................................................................................................................... | 466.3 | 373.6 |
Agency and Execution .................................................................................................. | 695.2 | 541.5 |
Market Making ................................................................................................................ | 207.8 | 153.9 |
Hedging and Investment Solutions ............................................................................. | 161.5 | 128.1 |
Corporate ........................................................................................................................ | 63.9 | 47.5 |
Total Revenue ...................................................................................................................... | 1,594.7 | 1,244.6 |
Adjusted Profit Before Tax ............................................................................................... | ||
Clearing ........................................................................................................................... | 247.3 | 185.0 |
Agency and Execution .................................................................................................. | 107.9 | 71.9 |
Market Making ................................................................................................................ | 65.6 | 33.3 |
Hedging and Investment Solutions ............................................................................. | 42.0 | 33.8 |
Corporate ........................................................................................................................ | (141.7) | (94.0) |
Total Adjusted Profit Before Tax .................................................................................... | 321.1 | 230.0 |
Year Ended December 31, | |||
2024 | 2023 | 2022 | |
($m, except percentage, earnings per share and ratio) | |||
Non-IFRS Measures | |||
Adjusted Profit Before Tax .............................................................. | 321.1 | 230.0 | 121.7 |
Adjusted Profit Before Tax Margin ................................................ | 20% | 18% | 17% |
Adjusted Profit After Tax Attributable to Common Equity .......... | 231.0 | 162.6 | 92.7 |
Adjusted Return on Equity ............................................................. | 30% | 26% | 17% |
Adjusted Basic Earnings per Share ($)1 ...................................... | 3.34 | 2.46 | 1.40 |
Adjusted Diluted Earnings per Share ($)2 .................................... | 3.07 | 2.31 | 1.37 |
Adjusted Sharpe ratio ..................................................................... | 5.2 | 4.3 | 4.1 |
Years Ended December 31, | |||
2024 | 2023 | 2022 | |
($ millions, except percentage and per share data) | |||
Profit After Tax | 218.0 | 141.3 | 98.2 |
Tax | 77.8 | 55.2 | 23.4 |
Goodwill impairment charge1 | — | 10.7 | 53.9 |
Bargain purchase gains2 | — | (0.3) | (71.6) |
Acquisition costs3 | — | 1.8 | 11.5 |
Amortisation of acquired brands and customer lists4 | 5.5 | 2.1 | 1.7 |
Activities relating to shareholders5 | 2.4 | 3.1 | 0.5 |
Employer tax on vesting of the growth shares6 | 2.2 | — | — |
Owner fees7 | 2.4 | 6.0 | 3.4 |
IPO preparation costs8 | 8.6 | 10.1 | 0.7 |
Fair value of the cash settlement option on the growth shares9 | 2.3 | — | — |
Public offering of ordinary shares10 | 1.9 | — | — |
Adjusted Profit Before Tax | 321.1 | 230.0 | 121.7 |
Tax and the tax effect on the Adjusting Items11 | (76.8) | (54.1) | (23.9) |
Profit attributable to AT1 note holders12 | (13.3) | (13.3) | (5.1) |
Adjusted Profit after Tax Attributable to Common Equity | 231.0 | 162.6 | 92.7 |
Profit Margin | 14% | 11% | 14% |
Adjusted Profit Before Tax Margin13 | 20% | 18% | 17% |
Basic Earnings per Share14 | $2.96 | $1.94 | $1.39 |
Diluted Earnings per Share15 | $2.72 | $1.82 | $1.36 |
Adjusted Basic Earnings per Share14 | $3.34 | $2.46 | $1.40 |
Adjusted Diluted Earnings per Share15 | $3.07 | $2.31 | $1.37 |
Total equity | 976.9 | 775.9 | 677.7 |
Common Equity16 | 775.6 | 629.2 | 523.9 |
Return on Equity17 | 25% | 19% | 17% |
Adjusted Return on Equity (%)16 | 30% | 26% | 17% |
Year Ended December 31, | |||
2024 | 2023 | 2022 | |
(millions, except ratios) | |||
Average monthly Profit After Tax ................................................... | $18.2 | $11.8 | $8.2 |
Standard deviation on monthly profit after tax(a) ......................... | $3.9 | $5.9 | $3.0 |
Sharpe ratio .................................................................................... | 4.7 | 2.0 | 2.8 |
Average monthly Adjusted Profit Before Tax ............................... | $26.8 | $19.2 | $10.1 |
Standard deviation on monthly Adjusted Profit Before Tax(a) .... | $5.2 | $4.5 | $2.5 |
Adjusted Sharpe ratio .................................................................. | 5.2 | 4.3 | 4.1 |
Year Ended December 31, | |||
2024 | 2023 | 2022 | |
FTE .................................................................................................... | 2,425 | 2,167 | 1,641 |
Average FTE .................................................................................... | 2,334 | 1,914 | 1,241 |
Average front-office FTE ................................................................ | 1,250 | 1,028 | 695.0 |
Revenue per front-office FTE ($m) .............................................. | 1.3 | 1.2 | 1.0 |
Adjusted Profit After Tax Attributable to Common Equity per FTE ($’000) ...................................................................................... | 99 | 84 | 75 |
Active clients .................................................................................... | 5,000 | 4,059 | 2,753 |
Average balances ($bn) ................................................................. | 13.5 | 12.9 | 9.1 |
Contracts cleared (m) ..................................................................... | 1,116 | 856 | 248 |
Total Capital Ratio (%) ................................................................... | 234 | 229 | 266 |
Client Activities | ||||||
Total | Repurchase Agreements | Securities | Derivatives | Client Balances | Residual | |
($bn) | ||||||
Cash and liquid assets1 ................... | 6.2 | — | — | — | 2.2 | 4.0 |
Trade receivables ............................. | 7.5 | — | — | — | 6.9 | 0.6 |
Reverse purchase agreements ...... | 2.5 | 2.5 | — | — | — | — |
Securities2 .......................................... | 6.5 | — | 6.5 | — | — | — |
Derivative assets .............................. | 1.2 | — | — | 1.2 | — | — |
Other assets3 ..................................... | 0.2 | — | — | — | — | 0.2 |
Goodwill and intangibles .................. | 0.2 | — | — | — | — | 0.2 |
Total assets ...................................... | 24.3 | 2.5 | 6.5 | 1.2 | 9.1 | 5.0 |
Trade Payables ................................. | 9.7 | — | — | — | 9.1 | 0.6 |
Repurchase agreements ................. | 2.3 | 2.3 | — | — | — | — |
Securities4 .......................................... | 6.7 | — | 6.7 | — | — | — |
Debt securities .................................. | 3.6 | — | — | — | — | 3.6 |
Derivative instruments ..................... | 0.7 | — | — | 0.7 | — | — |
Other liabilities5 ................................. | 0.3 | — | — | — | — | 0.3 |
Total liabilities ................................. | 23.3 | 2.3 | 6.7 | 0.7 | 9.1 | 4.5 |
Net assets ......................................... | 1.0 | |||||
Total equity ...................................... | 1.0 | |||||

Years Ended December 31, | ||
2024 | 2023 | |
(m) | ||
$ | $ | |
Net cash from operating activities ........................................................................... | 1,163.5 | 735.0 |
Net cash used in investing activities ....................................................................... | (35.3) | (97.6) |
Net cash used in financing activities ....................................................................... | (37.2) | (72.8) |
Contractual Obligations | Total | On demand | Less than 3 months | 3 to 12 months | 1 to 5 years | More than 5 years |
(m) | ||||||
Repurchase agreements ............................. | 2,305.8 | — | 2,305.8 | — | — | — |
Short securities ............................................. | 1,704.6 | — | 1,704.6 | — | — | — |
Amounts due to exchanges, clearing houses and other counterparties ................ | 1,501.5 | 1,218.8 | 282.0 | 0.7 | — | — |
Amounts payable to clients ......................... | 7,270.8 | 7,270.8 | — | — | — | — |
Trade payables ............................................. | 470.2 | 3.6 | 463.4 | 3.2 | — | — |
Other creditors .............................................. | 17.3 | 6.0 | 4.9 | 4.1 | 2.3 | — |
Stock lending ................................................. | 4,952.1 | 4,804.5 | 147.6 | — | — | — |
Short term borrowings .................................. | 152.0 | — | 152.0 | — | — | — |
Debt securities .............................................. | 3,604.5 | — | 1,235.8 | 883.8 | 1,434.9 | 50.0 |
Lease liabilities .............................................. | 104.3 | — | 3.7 | 10.3 | 52.9 | 37.4 |
Total non-derivative financial liabilities as of December 31, 2024 ........ | 22,083.1 | 13,303.7 | 6,299.8 | 902.1 | 1,490.1 | 87.4 |
Total | On demand | Less than 3 months | 3 to 12 months | 1 to 5 years | More than 5 years | |
(m) | ||||||
Repurchase agreements ............................. | 3,118.9 | — | 3,118.9 | — | — | — |
Short securities ............................................. | 1,924.8 | 1.3 | 1,923.5 | — | — | — |
Amounts due to exchanges, clearing houses and other counterparties1 .............. | 1,461.9 | 1,461.9 | — | — | — | — |
Amounts payable to clients1 ........................ | 4,899.1 | 4,899.1 | — | — | — | — |
Trade payables1 ............................................ | 16.1 | 16.1 | — | — | — | — |
Other creditors1 ............................................. | 18.1 | 6.5 | 9.8 | 1.8 | — | — |
Stock lending ................................................. | 2,323.3 | — | 2,323.3 | — | — | — |
Debt securities .............................................. | 2,216.3 | — | 440.2 | 868.2 | 889.4 | 18.5 |
Lease liabilities .............................................. | 57.8 | — | 3.4 | 10.4 | 31.5 | 12.5 |
Total non-derivative financial liabilities as of December 31, 2023 ........ | 16,036.3 | 6,384.9 | 7,819.1 | 880.4 | 920.9 | 31.0 |
Name | Age | Position |
Executive Officers | ||
Ian Lowitt ....................................................... | 61 | Chief Executive Officer and Director |
Rob Irvin ........................................................ | 47 | Chief Financial Officer and Director |
Paolo Tonucci ............................................... | 56 | Chief Strategist and CEO of Capital Markets |
Simon van den Born .................................... | 57 | President |
Thomas Texier .............................................. | 51 | Group Head of Clearing |
Nilesh Jethwa ............................................... | 46 | Chief Executive Officer of Marex Solutions |
Board of Directors | ||
Robert Pickering ........................................... | 65 | Chair |
Konstantin Graf von Schweinitz ................. | 63 | Director |
Sarah Ing ....................................................... | 58 | Director |
Linda Myers .................................................. | 60 | Director |
Roger Nagioff ................................................ | 60 | Director |
John W. Pietrowicz ...................................... | 60 | Director |
Henry Richards ............................................. | 40 | Director |
Element, purpose and link to strategy | Operation | Maximum opportunity | Performance measures |
Base salary Element of fixed pay that reflects the individual’s role, position, experience and contribution to the Group | Base salaries are paid in cash and typically reviewed annually, with any changes normally taking effect from January 1. Out-of-cycle reviews may be conducted if considered appropriate by the Committee. Base salaries are typically set with reference to comparator groups consisting of peers in the global financial services sector and wider industry. The Committee has the flexibility to set the salary of a new hire at a discount to the market and to realign it in subsequent years as the individual gains experience in the role. In exceptional circumstances, the Committee may agree to pay above market levels to secure or retain an individual who is considered by the Committee to possess significant and relevant experience that is critical to the delivery of the business strategy. | There is no prescribed maximum, annual increases will normally be made with reference to wider business performance, economic indicators, and increases made to the wider workforce. Higher increases may be made, for example, where there have been significant changes in the responsibility in a role, to recognise experience, where there are large variances to the market, in the case of a new Executive Director appointed on a salary below the market rate, or where there is a significant change in the relationship of the Company relative to a peer group. | Not applicable. |
Pension To provide a market competitive level of retirement provision | Mandatory retirement provision required by law (or similar) in the jurisdiction in which the Executive Director is resident will be provided. Pension provision is provided in the form of a defined contribution (DC) pension. | Any mandatory retirement provision required by law (or similar) in the jurisdiction in which the Executive Director is resident will be provided. Currently Executive Directors are entitled to an employer pension contribution of 6% of base salary up to a base of £123,600. Any changes to pension provision or opportunity to elect for a cash allowance instead of a pension contribution will be aligned to the pension provision available to all other qualifying employees. | Not applicable. |
Benefits To provide a market competitive level of benefits | Benefits that are currently provided include private medical, life insurance and income protection. The Committee can provide additional benefits it deems reasonable. | There is no defined maximum. Benefits are set at what are in the Committee’s opinion reasonable taking into account wider Company policy, market practice and individual circumstances. The Committee regularly reviews benefit costs to ensure they are appropriate and affordable. | Not applicable. |
Element, purpose and link to strategy | Operation | Maximum opportunity | Performance measures |
Annual bonus To motivate employees and incentivize delivery of annual performance targets | Annual bonuses may be paid partly in cash and partly in deferred equity pursuant to the Company's Deferred Bonus Programme (DBP) under the Global Omnibus Plan. The Committee will have regard to relevant regulatory requirements when determining the form and length of any deferral arrangements. Performance targets are normally set at the beginning of the performance period and are assessed at the end of the financial period. The Committee has discretion to adjust the formulaic outcome upwards or downwards to ensure outcomes reflect overarching Company performance and/or management contribution. Any adjustment made using this discretion will be explained. Malus and clawback apply. Refer to the notes to the policy table. Awards are still outstanding under legacy deferred bonus plans. Refer to the notes to the policy table | The maximum annual bonus that may be awarded will be 600% of salary. The maximum opportunity for each year will be advised to the CEO and CFO at the beginning of the performance year. | Performance measures may include both business and individual performance and may include a combination of financial and non-financial measures. The majority of the bonus will be linked to financial performance. Detail on performance measures and the associated rationale for their selection will be disclosed in the relevant annual report. The Committee has discretion to amend performance measures and targets after they have been set if events occur that the Committee considers mean that the original performance measures and/or targets are no longer a fair test of performance |
Equity incentives To motivate and incentivize delivery of sustained, long-term performance and to align participants’ interests to that of shareholders | Allows for grants of equity incentive awards under the Global Omnibus Plan. Executive Directors are eligible to participate in equity incentive programmes that are implemented under the Global Omnibus Plan from time to time Equity awards are typically made in the form of performance shares under the Long-term Incentive Plan (LTIP) linked to Group performance over a three-year performance period. Both the Executive Directors participate in an annual LTIP and the CFO has been awarded a one-off retention long term incentive plan award (RLTIP) granted in connection with the IPO. The Committee may deem it appropriate to deliver LTIP awards in other forms or using alternative vehicles under the Global Omnibus Plan. These vehicles may include, but are not limited to, share options, restricted shares, restricted stock units, performance shares, performance share units, phantom stock, and/or any other equity-based or cash-based LTI instruments as may be considered appropriate from time to time. When determining award values and the form of vehicle used, the Committee will consider the certainty of value associated with the relevant delivery vehicle and have due regard for the overall limits in the policy Under the LTIP and RLTIP, the Committee has discretion to allow participants to receive dividend equivalents in relation to the period between grant and vesting in respect of awards that vest. The Committee has discretion to adjust the formulaic outcome upwards or downwards to ensure outcomes reflect overarching Company performance and/or management contribution. Any adjustment made using this discretion will be explained. Malus and clawback apply. Refer to the notes to the policy table. The CEO has an outstanding award under a legacy annual long term incentive. Refer to the notes to the policy table. | The maximum annual long- term incentive award that may be awarded for each year is up to 200% of Base Salary with the actual level of awarded determined each year. Typically, under the LTIP, 50% of the maximum award typically vests for achieving threshold performance, increasing on a graduated scale to 100% of the maximum opportunity vesting for achieving maximum performance. For exceptional performance, the number of shares receivable will increase by 15% (i.e. up to 230% of salary if a 200% of base salary grant is made and if the pre-set exceptional performance target for the three year performance period has been met. | The Committee selects performance measures that support the Company’s long- term strategic priorities, provide a direct link with shareholder value and ensure a clear line of sight for participants between performance and reward. Detail on performance measures and the associated rationale for their selection will be disclosed in the relevant annual report. The Committee has discretion to amend performance measures and targets after they have been set if events occur that the Committee considers mean that the original performance measures and/or targets are no longer a fair test of performance. |
Notice period | The notice period would be 12 months in the case of notice being given by both the Company and the Executive Director. An Executive Director may be placed on garden leave during the notice period. |
Payment in lieu of notice ("PILON") | The contract may include provision for the contract to be terminated summarily by paying a PILON comprising basic salary and pension for the remainder of the notice period. PILON will not apply on termination for misconduct. The Company will have discretion to pay on a phased basis, subject to mitigation. |
Retirement benefits | The service contract may include entitlement to retirements benefits, subject to the provisions and limits set out in this Remuneration Policy. The entitlement to retirement benefits may continue during any notice period. |
Benefits | The service contract may include entitlement to other benefits, subject to the provisions and limits set out in this Remuneration Policy. The entitlement to other benefits may continue during any notice period. |
Cash and Equity incentive plans | The Executive Director will be eligible to be considered (at the Committee's discretion) to participate in the Company's annual bonus arrangements and long term incentive arrangements (whether cash or equity based). Participation in such arrangements will be subject to the provisions and limits set out in this Remuneration Policy. |
Element | Operation | Maximum Opportunity | Performanc e Measures |
Fees To attract and retain high-calibre Non- Executive Directors | Fees will typically consist of a basic fee for Non-Executive Director responsibilities plus incremental fees for additional roles/responsibilities such as membership and chairmanship of Board committees and the Senior Independent Non-Executive Director role. The Non-Executive Directors receive a portion of their fees in cash and a portion in the form of an award of additional shares (see Equity Awards section). The Non-Executive Directors do not receive any pension from the Company, nor do they participate in any performance-related incentive plans. | There is no prescribed maximum. The fee levels are reviewed on an annual basis and may be increased by the Group taking into account factors such as wider economic conditions, the time commitment of the role, and market levels in comparable companies. | Not applicable. |
Benefits To reimburse Directors for reasonable expenses incurred | Non-Executive Directors may receive travel, accommodation and other business-related expenses incurred in carrying out their duties. Non-Executive Directors are entitled to receive officers' liability insurance. Other reasonable benefits may be provided to Non-Executive Directors at the discretion of the Committee. | No formal maximum | Not applicable |
Equity Awards To attract and retain high-calibre Non- Executive Directors. For public companies listed in the United States, equity-based remuneration is a standard component of Non-Executive Director remuneration | As part of their fees, Non-Executive Directors are eligible to receive an annual fixed award over ordinary shares in the Company pursuant to the Non-employee Sub-Plan of the Global Omnibus Plan. Any shares awarded will not be subject to performance conditions. Awards vest on a daily basis over a 12 month period and are not subject to any post vesting sale restrictions. | No formal maximum | Not applicable |
Date of letter of appointment | Unexpired term at AGM | |
Robert Pickering | 6/5/2024 | 2 years |
Linda Myers | 6/5/2024 | 2 years |
Sarah Ing | 6/5/2024 | 2 years |
Konstantin Graf von Schweinitz | 6/5/2024 | 2 years |
John Pietrowicz | 6/5/2024 | 2 years |
Henry Richards | 6/14/2024 | 2 years |
Roger Nagioff | 6/14/2024 | 2 years |
g Fixed Remuneration | ||
g Annual Bonus | ||
g LTIP | ||


g Fixed Remuneration | ||
g Annual Bonus | ||
g LTIP | ||
Name | Salary | Benefits | Pension Benefits | Annual Bonus | LTIP | Other | Total | Total fixed remuneration | Total variable remuneration |
Ian Lowitt | $1,279,553 | $19,127 | $— | $5,642,827 | $— | $— | $6,941,506 | $1,298,680 | $5,642,827 |
Rob Irvin | $607,787 | $2,002 | $9,489 | $1,010,447 | $— | $— | $1,629,725 | $619,278 | $1,010,447 |
Name | Salary | Benefits | Pension Benefits | Annual Bonus | LTIP | Other | Total | Total fixed remuneration | Total variable remuneration |
Ian Lowitt | $1,242,000 | $23,626 | $— | $4,806,540 | $— | $3,726 | $6,075,892 | $1,265,626 | $4,810,266 |
Rob Irvin1 | $410.815 | $1,426 | $7,676 | $580,014 | $— | $— | $999,930 | $419,916 | $580,014 |
Financial measure | Weighting | Threshold (25% of max) | Target (50% of max) | Maximum (100% of max) | 2024 outcome | % achieved | Bonus outcome after weighting (% of max) |
Adjusted Operating Profit Before Tax | 60% | $230m | $255m | $280m | $321m | 100 | 100 |
Target | Weighting1 (% of bonus) | Assessment |
Complete successful listing on Nasdaq | 10% | Successful listing accomplished in April and first secondary offering in October was also successful. Both offerings heavily oversubscribed as a result of extensive pre-deal marketing by Management. Top quartile post IPO stock price performance, at 64%. |
Drive the execution of growth plans for 2025 and beyond including overseeing the integration of acquisitions and increasing cross selling efforts with clients | 8% | Firm has grown 29% in revenue and 39% in Operating PBT, well ahead of competition and without material contribution from new acquisitions in 2024. |
Lead investor engagement | 5% | Bluechip shareholder register with name brand funds represented in Top Ten. 182 meetings with investors in 2024. |
Target | Weighting1 (% of bonus) | Assessment |
Build an effective ESG strategy which can be embedded throughout Marex | 2% | Continued to invest in environmental business. Drove investment in our people with the launch of Marex Academy, invested in a new Graduate Programme, expanded our partnership with Future Frontiers and supported charitable fund raising in the Company through the matching programme. Support for International Women’s Day, Multicultural months Pride, Pink October, World Mental Health Day and Movember |
Set Tone from the Top to exemplify firm-wide culture, conduct and behaviour standards, promote positive employee engagement and diversify our employee base | 5% | Engagement Survey results confirm satisfied employee base with score flat to 2023 at high 78 despite significant additional challenges in 2024. Consistently promote a “grow firm safely” message.Regular Town Halls to deliver message and tone from top. |
Ensure Marex operates within the Board's approved risk appetite, complies with legal and regulatory obligations and maintains a strong control framework and overall operational resilience | 10% | Market risk well inside Board Risk Appetite and “loss days” consistent with history. Credit risk within Appetite; limited realised losses. |
Total for Strategic Measures | 38/40 |
Target | Weighting1 (% of bonus) | Assessment |
Lead engagement with existing investors and potential investors | 5% | Delivered successful presentation at the Analyst day, ahead of the IPO, setting out the financial building blocks and drivers of the Company.Presented the 2Q & 3Q financial results to the market and answered any financial questions from analysts on the result calls |
Deliver PCAOB audits for all outstanding years and all support materials | 5% | Delivered the 2023 PCAOB audit, with minimal adjustments identified by the auditors, in a timeframe that allowed the IPO to launch in April 2024. |
Move firm towards a controls-based audit for 2026 and launch and drive a “SOX” compliance project for 2025 delivery | 10% | Move firm towards a controls-based audit for 2026 and launch and drive a “SOX” compliance project for 2025 delivery. Embedded quarterly reporting within the finance department, including all the necessary controls, to support external announcements to the market. |
Build an effective ESG strategy which can be embedded throughout Marex | 5% | Chaired the sustainability committee and continued to drive forward the Firm’s agenda, including building out the ability to meet our reporting requirements for 2024. |
Set Tone from the Top to exemplify firm-wide culture, conduct and behaviour standards | 5% | Launched a Finance Transformation program (“Finance 25”) which includes improving the connectivity and culture in finance |
Ensure Marex operates within the board's approved risk appetite, complies with legal and regulatory obligations and maintains a strong control framework and overall operational resilience | 10% | Built out a Group Liquidity Stress Framework. Developed a financial reporting framework.Ensured compliance with CASS framework. |
Total for Strategic Measures | 35/40 |
Ian Lowitt | Rob Irvin | |
Percentage of maximum annual bonus awarded | 98% | 95% |
Quantum of award – total | $5,642,816 | $1,010,445 |
Quantum of award – paid in cash | $3,024,856 | $672,883 |
Quantum of awards – deferred into share awards | $2,618,060 | $337,562 |
Financial measure | Weighting | Threshold (20% of max) | Straight Line Apportionment | Maximum (100% of max) |
Growth in Adjusted Operating Profit After Tax | 100% | average of 5% pa over the Performance Period | more than 5% and less than 12% over the Performance Period | average of 12% pa over the Performance Period |
Date of grant | Type of award1 | Form of award | Number of shares subject to award | Shares receivable if minimum performance is achieved (%) | Face value of award at award date | End of period for which performance targets need to be achieved | Vesting schedule | |
Ian Lowitt | 5 June 2024 | Annual LTIP | Performance -based conditional award | 99,572 | 20% | $1,863,000 | 31 December 2026 | Awards will vest in a single tranche on the third anniversary of grant (or the date on which performance conditions are assessed, if later). |
17 May 2024 | DBP | Service- based conditional award | 112,564 | N/A | $2,138,724 | N/A | Awards will vest in three equal tranches on the first, second and third anniversary of grant (or the date on which the audited accounts are published in each of those years if later). | |
Rob Irvin | 5 June 2024 | Annual LTIP | Performance -based conditional award | 27,681 | 20% | $517,914 | 31 December 2026 | Awards will vest in a single tranche on the third anniversary of grant (or the date on which performance conditions are assessed, if later). |
6 June 2024 | Retention LTIP | Performance -based conditional award | 39,473 | 20% | $750,000 | 31 December 2026 | Awards will vest in a single tranche on the third anniversary of grant (or the date on which performance conditions are assessed, if later). | |
17 May 2024 | DBP | Service- based conditional award | 7,412 | N/A | $140,843 | N/A | Awards vest in three equal tranches on the first, second and third anniversary of grant (or the date on which the audited accounts are published in each of those years if later). |
Name | Base fees1 | Other fees2 | Equity awards4 | Total |
Robert Pickering | $357,208 | $— | $26,076 | $374,629 |
Linda Myers | $100,765 | $44,784 | $26,076 | $162,970 |
Sarah Ing | $100,765 | $47,450 | $26,076 | $165,635 |
Konstantin Graf von Schweinitz | $100,765 | $37,320 | $26,076 | $155,506 |
Roger Nagioff | $74,599 | $— | $26,076 | $92,019 |
Henry Richards | $74,599 | $— | $26,076 | $92,017 |
Madelyn Antoncic3 | $95,876 | $26,009 | $19,680 | $135,033 |
John Pietrowicz | $74,599 | $8,776 | $26,076 | $100,796 |
Name | Base fees1 | Other fees2 | Equity awards | Total |
Robert Pickering | $142,830 | $27,945 | N/A | $170,775 |
Sarah Ing | $86,940 | $38,813 | N/A | $125,753 |
Konstantin Graf von Schweinitz | $86,940 | $38,813 | N/A | $125,753 |
Roger Nagioff | N/A | N/A | N/A | N/A |
Date of grant | Type of award | Form of award | Number of shares subject to award | Face value of award at award date ($, 000s) | Vesting schedule | |
Robert Pickering | 11/8/2024 | Annual Grant | Nil-cost conditional share award | 6,315 | $120,000 | Awards vest in a single tranche on the first anniversary of the grant date. |
Linda Myers | 11/8/2024 | Annual Grant | Nil-cost conditional share award | 6,315 | $120,000 | Awards vest in a single tranche on the first anniversary of the grant date. |
Sarah Ing | 11/8/2024 | Annual Grant | Nil-cost conditional share award | 6,315 | $120,000 | Awards vest in a single tranche on the first anniversary of the grant date. |
Konstantin Graf von Schweinitz | 11/8/2024 | Annual Grant | Nil-cost conditional share award | 6,315 | $120,000 | Awards vest in a single tranche on the first anniversary of the grant date. |
Roger Nagioff | 11/8/2024 | Annual Grant | Nil-cost conditional share award | 6,315 | $120,000 | Awards vest in a single tranche on the first anniversary of the grant date. |
Henry Richards | 11/8/2024 | Annual Grant | Nil-cost conditional share award | 6,315 | $120,000 | Awards vest in a single tranche on the first anniversary of the grant date. |
Madelyn Antoncic | 11/8/2024 | Annual Grant | Nil-cost conditional share award | 6,315 | $120,000 | Awards vest in a single tranche on the first anniversary of the grant date. |
John Pietrowicz | 11/8/2024 | Annual Grant | Nil-cost conditional share award | 6,315 | $120,000 | Awards vest in a single tranche on the first anniversary of the grant date. |
Interests in shares excluding outstanding scheme interests | Outstanding scheme interests | Total of all share interests and outstanding scheme interests | ||||
Unvested scheme interests (not subject to performance measures) | Unvested scheme interests (subject to performance measures) | Vested but unexercised scheme interests | Total shares subject to outstanding scheme interests | |||
Ian Lowitt | 2,537,509 | 356,922 | 423,226 | N/A | 780,148 | 3,317,657 |
Rob Irvin | 2,477 | 16,758 | 67,154 | N/A | 83,912 | 86,389 |
Robert Pickering | 17,894 | 6,315 | N/A | N/A | 6,315 | 24,209 |
Sarah Ing | 1,579 | 6,315 | N/A | N/A | 6,315 | 7,894 |
Konstantin Graf von Schweinitz | 7,893 | 6,315 | N/A | N/A | 6,315 | 14,208 |
Linda Myers | 13,157 | 6,315 | N/A | N/A | 6,315 | 19,472 |
Madelyn Antoncic | 26,315 | 692 | N/A | N/A | 692 | 27,007 |
John Pietrowicz | 13,157 | 6,315 | N/A | N/A | 6,315 | 19,472 |
Henry Richards | 0 | 6,315 | N/A | N/A | 6,315 | 6,315 |
Roger Nagioff | 0 | 6,315 | N/A | N/A | 6,315 | 6,315 |
Description | Type | Vesting dates | At 1 January 20241 | Changes during the year | At 31 December 2024 | |||
Granted | Lapsed | Released | ||||||
Ian Lowitt | Legacy Retention LTIP | Conditional award | 3/31/2025 | 245,811 | 245,811 | |||
Ian Lowitt | Legacy 2022 Annual LTIP | Conditional award | 9/27/2026 | 77,843 | 77,843 | |||
Ian Lowitt | Legacy 2023 Annual LTIP | Conditional award | 6/5/2027 | 99,572 | 99,572 | |||
Ian Lowitt | 2023 DBP | Conditional award | 17/5/2025 17/5/2026 17/5/2027 | 112,564 | 112,564 | |||
Ian Lowitt | 2022 Legacy Deferred Bonus Plan | Conditional award | 04/05/202 504/05/20 26 | 139,420 | 46,473 | 92,947 | ||
Ian Lowitt | 2021 Legacy Deferred Bonus Plan | Conditional award | 3/31/2022 | 17,403 | 8,701 | 8,702 | ||
Ian Lowitt | Legacy Conditional Award | Conditional award | 4/28/2025 | 142,703 | 142,703 | |||
Rob Irvin | 2022 Legacy Deferred Bonus Plan | Conditional award | 04/05/202 504/05/20 26 | 14,019 | 4,673 | 9,346 | ||
Rob Irvin | 2023 DBP | Conditional award | 17/5/2025 17/5/2026 17/5/2027 | 7,412 | 7,412 | |||
Rob Irvin | Legacy 2023 Annual LTIP | Conditional award | 6/5/2027 | 27,681 | 27,681 | |||
Rob Irvin | 2024 Retention LTIP | Conditional award | 6/6/2027 | 39,473 | 39,473 | |||
Robert Pickering | 2024 NED Awards | Conditional award | 11/8/2025 | 6,315 | 6,315 | |||
Sarah Ing | 2024 NED Awards | Conditional award | 11/8/2025 | 6,315 | 6,315 | |||
Konstantin Graf von Schweinitz | 2024 NED Awards | Conditional award | 11/8/2025 | 6,315 | 6,315 | |||
Linda Myers | 2024 NED Awards | Conditional award | 11/8/2025 | 6,315 | 6,315 | |||
Madelyn Antoncic | 2024 NED Awards | Conditional award | 11/8/2025 | 6,315 | 5,623 | 692 | ||
John Pietrowicz | 2024 NED Awards | Conditional award | 11/8/2025 | 6,315 | 6,315 | |||
Henry Richards | 2024 NED Awards | Conditional award | 11/8/2025 | 6,315 | 6,315 | |||
Roger Nagioff | 2024 NED Awards | Conditional award | 11/8/2025 | 6,315 | 6,315 |
Director | Number of eligible shares as at 31 December 20241 | Value of shares held as at 31 December 20242 | Shareholding as % of base salary as at 31 December 2024 | Shareholding requirement (% of salary) |
Ian Lowitt | 2,651,042 | $82,632,979 | 6458% | 300% |
Rob Irvin | 11,358 | $354,029 | 58% | 200% |
2024 | |
CEO single figure of remuneration | $5.942m |
Annual Bonus as a % of maximum opportunity (%) | 98% |
LTIP award as a % of maximum opportunity (%) | 100% |

Change in salary / NED fees | Change in benefits | Change in bonus | |||||||||||||
2023 to 2024 | 2022 to 2023 | 2021 to 2022 | 2020 to 2021 | 2019 to 2020 | 2023 to 2024 | 2022 to 2023 | 2021 to 2022 | 2020 to 2021 | 2019 to 2020 | 2023 to 2024 | 2022 to 2023 | 2021 to 2022 | 2020 to 2021 | 2019 to 2020 | |
Ian Lowitt | —% | 33% | (63)% | —% | 28% | (20)% | 7% | (8)% | (6)% | (5)% | 14% | 6% | 195% | 36% | (7)% |
Rob Irvin2 | 19% | N/A | N/A | N/A | N/A | —% | N/A | N/A | N/A | N/A | 41% | N/A | N/A | N/A | N/A |
Robert Pickering3 | 103% | 38% | —% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Linda Myers4 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sarah Ing5 | 14% | 1% | —% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Konstantin Graf von Schweinitz6 | 8% | —% | —% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Roger Nagioff | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Henry Richards7 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Madelyn Antoncic8 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
John Pietrowicz9 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Year | Method | 25th percentile pay ratio | Total pay and benefits (25th percentile) | Salary component of total pay and benefits (25th percentile) | Median pay ratio | Total pay and benefits (50th percentile | Salary component of total pay and benefits (50th percentile) | 75th percentile pay ratio | Total pay and benefits (75th percentile) | Salary component of total pay and benefits (75th percentile) |
2024 | A | 67:1 | $102,683 | $76,773 | 35:1 | $200,864 | $108,761 | 14:1 | $381,880 | $159,943 |
Current Year | |
Employee remuneration (USD m) | 971.6 |
Distributions to shareholders (USD m) | 77.1 |
Executive Director | Base salary at 1st Jan 2024 ($) | Base salary at 1st Jan 2025 ($) | % change |
Ian Lowitt | $1,279,550 | $1,279,550 | —% |
Rob Irvin | $607,786 | $639,775 | 5% |
Element | Weighting | |
Financial Measures | 75% | |
Adjusted Operating PBT | 37.5% | |
EPS | 37.5% | |
Strategic Measures | 25% | |
Total | 100% |
Financial measure | Weighting | Threshold (50% of max) | Straight Line Apportionment | Maximum (100% of max) |
Growth in Adjusted Operating Profit After Tax | 50% | average of 5% pa over the Performance Period | more than 5% and less than 11% over the Performance Period | average of 11% pa over the Performance Period |
Growth in Adjusted EPS | 50% | average of 5% pa over the Performance Period | more than 5% and less than 10% over the Performance Period | average of 10% pa over the Performance Period |
Non-Executive Director | Base Fee1 at 1st June 2024 ($) | Base Fee at 1st Jan 2025 ($) | % change |
Robert Pickering | $383,865 | $383,865 | —% |
Linda Myers2 3 | $108,761 | $108,761 | —% |
Sarah Ing2 | $108,761 | $108,761 | —% |
Konstantin Graf von Schweinitz2 | $108,761 | $108,761 | —% |
Roger Nagioff | $108,761 | $108,761 | —% |
Henry Richards | $108,761 | $108,761 | —% |
John Pietrowicz3 | $108,761 | $108,761 | —% |
Member | Attendance1 |
Linda Myers | 4/4 |
Robert Pickering | 4/4 |
Sarah Ing | 4/4 |
Roger Nagioff | 0/1 |
Henry Richards | 1/1 |
Jeremy Isaacs CBE | 3/3 |
Joe Cohen | 3/3 |
Year Ended December 31, | |||
2024 | 2023 | 2022 | |
Employees by geography | |||
United Kingdom ............................................................................... | 1,095 | 956 | 794 |
Europe ............................................................................................... | 218 | 196 | 58 |
North America .................................................................................. | 709 | 688 | 617 |
APAC ................................................................................................. | 200 | 171 | 106 |
Other Regions(1) ............................................................................... | 118 | 63 | 15 |
Total ................................................................................................... | 2,340 | 2,074 | 1,590 |
Employees by role | |||
Front-office employees ................................................................... | 1,241 | 1,175 | 858 |
Control and support employees .................................................... | 1,099 | 899 | 732 |
Total ................................................................................................... | 2,340 | 2,074 | 1,590 |
Name of beneficial owner | Number | % |
5% or Greater Shareholders | ||
Amphitryon Limited(1) ................................................................................................. | 14,370,304 | 20.44 |
MASP Investor Limited Partnership(2) ..................................................................... | 10,083,349 | 14.35 |
Ocean Ring Jersey Co Limited(3) ............................................................................. | 9,444,092 | 13.44 |
Directors and Executive Officers(4) | ||
Ian Lowitt ..................................................................................................................... | 2,934,731 | 4.15 |
Robert Irvin ................................................................................................................. | 2,477 | * |
Paolo Tonucci ............................................................................................................. | 1,315,225 | 1.86 |
Simon van den Born .................................................................................................. | 1,309,302 | 1.86 |
Thomas Texier ............................................................................................................ | 124,605 | * |
Nilesh Jethwa ............................................................................................................. | 522,501 | * |
Robert Pickering ........................................................................................................ | 17,894 | * |
Madelyn Antoncic(5) ................................................................................................... | 26,315 | * |
Konstantin Graf von Schweinitz .............................................................................. | 7,893 | * |
Sarah Ing ..................................................................................................................... | 1,579 | * |
Linda Myers ................................................................................................................ | 13,157 | * |
Roger Nagioff ............................................................................................................. | — | * |
John W. Pietrowicz .................................................................................................... | 13,157 | * |
Henry Richards .......................................................................................................... | — | * |
All executive officers and directors as a group (14 persons) ..................... | 6,288,836 | 8.81 |
2024 | 2023 | |
$m | $m | |
Audit Fees ............................................................................................................................... | 10.9 | 7.2 |
Audit Related Fees ................................................................................................................ | 2.1 | 3.7 |
All Other Fees ........................................................................................................................ | 0.0 | 0.0 |
Total ........................................................................................................................................ | 13.0 | 10.9 |
Period1 | (a) Total number of shares (or units) purchased | (b) Average price paid per share (or units) | (c) Total number of shares (or units) purchased as part of publicly announced plans or programs | (d) Maximum number (or approximate dollar value) of shares (or units) that may yet be purchased under the plans or programs |
6/27/2024 | 8,343 | 19.05 | 0 | 0 |
Incorporation by Reference | ||||||
Exhibit No. | Description | Form | File No. | Exhibit No. | Filing Date | Filed / Furnished |
F-1 | 333-278231 | 3.1 | April 26, 2024 | |||
* | ||||||
* | ||||||
* | ||||||
F-1 | 333-282656 | 4.1 | October 22, 2024 | |||
F-1 | 333-282656 | 4.2 | October 22, 2024 | |||
F-1 | 333-278231 | 10.3 | April 15, 2024 | |||
F-1 | 333-278231 | 10.4 | April 15, 2024 | |||
F-1 | 333-278231 | 10.5 | April 15, 2024 | |||
F-1 | 333-278231 | 10.6 | April 15, 2024 | |||
F-1 | 333-278231 | 10.7 | April 15, 2024 | |||
S-8 | 333-278953 | 99.5 | April 26, 2024 | |||
F-1 | 333-278231 | 10.12 | April 15, 2024 | |||
F-1 | 333-278231 | 10.11 | April 15, 2024 | |||
S-8 | 333-278953 | 99.6 | April 26, 2024 | |||
* | ||||||
* | ||||||
* | ||||||
** | ||||||
** | ||||||
* | ||||||
* | ||||||
101.INS | Inline XBRL Instance Document – the instance document appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. | * | ||||
101.SCH | Inline XBRL Taxonomy Extension Schema Document. | * | ||||
101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document. | * | ||||
101.DEF | Inline XBRL Taxonomy Definition Linkbase Document. | * | ||||
101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document. | * | ||||
101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document | * |
MAREX GROUP PLC | ||
Date: March 20, 2025 | By: | /s/ Ian Lowitt |
Name: | Ian Lowitt | |
Title: | Chief Executive Officer | |
Date: March 20, 2025 | By: | /s/ Rob Irvin |
Name: | Rob Irvin | |
Title: | Chief Financial Officer | |
Date: March 20, 2025 | By: | /s/ Ian Lowitt |
Chief Executive Officer | ||
(Principal Executive Officer) |
Date: March 20, 2025 | By: | /s/ Rob Irvin |
Chief Financial Officer | ||
(Principal Financial Officer) |
Date: March 20, 2025 | By: | /s/ Ian Lowitt |
Chief Executive Officer | ||
(Principal Executive Officer) |
Date: March 20, 2025 | By: | /s/ Rob Irvin |
President and Chief Financial Officer | ||
(Principal Financial Officer) |

Financial Statements | |
2024 | 2023 | 2022 | ||||
Notes | $m | $m | $m | |||
Commission and fee income | ||||||
Commission and fee expense | ( | ( | ( | |||
Net commission income | 5 | |||||
Net trading income | 5 | |||||
Interest income | 6 | |||||
Interest expense | 6 | ( | ( | ( | ||
Net interest income | 6 | |||||
Net physical commodities income | 5 | |||||
Revenue | 5 | |||||
Expenses: | ||||||
Compensation and benefits | 7 | ( | ( | ( | ||
Depreciation and amortisation | 12, 13, 30 | ( | ( | ( | ||
Other expenses | 8 | ( | ( | ( | ||
Impairment of goodwill | 11 | ( | ( | |||
Provision for credit losses | ( | ( | ||||
Bargain purchase gain on acquisitions | 15 | |||||
Other income | ||||||
Share of results in associates and joint ventures | ( | |||||
Profit before tax | ||||||
Tax | 9 | ( | ( | ( | ||
Profit after tax | ||||||
Attributable to: | ||||||
Ordinary shareholders of the company | ||||||
Other equity holders1 | ||||||
Earnings per share2 | ||||||
Basic (dollars per share) | 33 | |||||
Diluted (dollars per share) | 33 |
2024 | 2023 | 2022 | ||||
Notes | $m | $m | $m | |||
Profit after tax | ||||||
Other comprehensive income | ||||||
Items that may be reclassified subsequently to profit and loss: | ||||||
Cash flow hedges | ||||||
Fair value (loss)/gain arising on hedging instruments during the year | ( | |||||
Deferred tax on hedging instruments | 9(a) | ( | ( | |||
Currency translation adjustments | ( | |||||
Items that will not be recycled to profit or loss: | ||||||
Change in fair value of financial liabilities designated at FVTPL due to own credit risk | ( | ( | ( | |||
Deferred tax on change in fair value of financial liabilities designated at FVTPL due to own credit risk | 9(a) | |||||
Fair value gain/(loss) on investments in equity instruments designated as at FVTOCI | 14 | ( | ||||
Deferred tax on revaluation of investments | 9(a) | ( | ( | |||
Other comprehensive loss, net of tax | ( | ( | ( | |||
Total comprehensive income | ||||||
Attributable to: | ||||||
Ordinary shareholders of the Company | ||||||
Other equity holders1 |
31 December | 31 December | 1 January | ||||
2024 | 2023 | 2023 | ||||
Notes | $m | $m | $m | |||
Restated1 | ||||||
Assets | ||||||
Non-current assets | ||||||
Goodwill | 11 | |||||
Intangible assets | 12 | |||||
Property, plant and equipment | 13 | |||||
Right of use asset | 30 | |||||
Investments | 14 | |||||
Investment in associate | ||||||
Deferred tax | 23 | |||||
Treasury instruments (unpledged) | 16 | |||||
Treasury instruments (pledged as collateral) | 16 | |||||
Total non-current assets | ||||||
Current assets | ||||||
Corporate income tax receivable | ||||||
Trade and other receivables | 20 | |||||
Inventory | 19 | |||||
Equity instruments (unpledged) | 31(b) | |||||
Equity instruments (pledged as collateral) | 31(b) | |||||
Derivative instruments | 22 | |||||
Stock borrowing | 31(b) | |||||
Treasury instruments (unpledged) | 16 | |||||
Treasury instruments (pledged as collateral) | 16 | |||||
Fixed income securities (unpledged) | 17 | |||||
Reverse repurchase agreements | 18 | |||||
Cash and cash equivalents | ||||||
Total current assets | ||||||
Total assets |
31 December | 31 December | 1 January | ||||
2024 | 2023 | 2023 | ||||
Notes | $m | $m | $m | |||
Restated1 | ||||||
Liabilities | ||||||
Current liabilities | ||||||
Repurchase agreements | 18 | |||||
Trade and other payables | 24 | |||||
Stock lending | 31(b) | |||||
Short securities | 31(b) | |||||
Short term borrowings | 21 | |||||
Lease liability | 30 | |||||
Derivative instruments | 22 | |||||
Corporate tax | ||||||
Debt securities | 31(b) | |||||
Provisions | ||||||
Total current liabilities | ||||||
Non-current liabilities | ||||||
Lease liability | 30 | |||||
Long term borrowings | 21 | |||||
Debt securities | 31(b) | |||||
Deferred tax liability | 23 | |||||
Total non-current liabilities | ||||||
Total liabilities | ||||||
Total net assets | ||||||
Equity | ||||||
Share capital | 26 | |||||
Share premium | ||||||
Additional Tier 1 capital (AT1) | 28 | |||||
Retained earnings | ||||||
Own shares | 27 | ( | ( | ( | ||
Other reserves | 29 | ( | ( | ( | ||
Total equity |
Share capital | Share premium | Additional Tier 1 capital (AT1) | Retained earnings | Own Shares | Other reserves | Total | ||
Group | Notes | $m | $m | $m | $m | $m | $m | $m |
At 1 January 2022 | ( | |||||||
Profit after tax for the period | — | — | — | — | ||||
Gain on cash flow hedge | — | — | — | — | ||||
Deferred tax on cash flow hedge reserve | — | — | — | — | — | ( | ( | |
Change in fair value of financial liabilities designated at FVTPL due to own credit risk | — | — | — | — | — | ( | ( | |
Deferred tax on change in fair value of financial liabilities designated at FVTPL due to own credit risk | — | — | — | — | — | |||
Loss on revaluation of investments | — | — | — | — | — | ( | ( | |
Deferred tax on revaluation of investments | — | — | — | — | — | |||
Total comprehensive income for the period | — | — | — | ( | ||||
Additional (AT1) capital | — | — | — | — | — | |||
AT1 dividends paid | — | — | ( | — | — | — | ( | |
Repurchase of own shares | — | — | — | — | ( | — | ( | |
Share-based payments | — | — | — | — | — | |||
Other movements | — | — | — | ( | — | |||
At 31 December 2022 and 1 January 2023 | ( | ( | ||||||
Profit after tax for the period | — | — | — | — | ||||
Gain on cash flow hedge | — | — | — | — | — | |||
Deferred tax on cash flow hedge reserve | 23 | — | — | — | — | — | ( | ( |
Change in fair value of financial liabilities designated at FVTPL due to own credit risk | — | — | — | — | — | ( | ( | |
Deferred tax on change in fair value of financial liabilities designated at FVTPL due to own credit risk | 23 | — | — | — | — | — | ||
Deferred tax on revaluation of investments | 23 | — | — | — | — | — | ( | ( |
Currency translation adjustments | — | — | — | — | — | |||
Total comprehensive income for the period | — | — | — | ( | ||||
AT1 dividends paid | 28 | — | — | ( | — | — | — | ( |
Ordinary dividends paid | 10 | — | — | — | ( | — | — | ( |
Repurchase of own shares | — | — | — | — | ( | — | ( | |
Share-based payments | 35 | — | — | — | — | — |
Deferred tax on share-based payments | 23 | — | — | — | — | — | ||
Share settlement (share-based payments) | — | — | — | ( | — | |||
Other movements | — | — | — | ( | — | — | ( | |
At 31 December 2023 and 1 January 2024 | ( | ( | ||||||
Profit after tax for the period | — | — | — | — | ||||
Fair value loss on hedging instruments | — | — | — | — | — | ( | ( | |
Deferred tax on hedging instruments | 23 | — | — | — | — | |||
Change in fair value of financial liabilities designated at FVTPL due to own credit risk | — | — | — | — | — | ( | ( | |
Deferred tax on change in fair value of financial liabilities designated at FVTPL due to own credit risk | 23 | — | — | — | — | — | ||
Gain on revaluation of investments | — | — | — | — | — | |||
Deferred tax on revaluation of investments | 23 | — | — | — | — | — | ( | ( |
Currency translation adjustments | — | — | — | — | — | ( | ( | |
Total comprehensive income for the period | — | — | — | ( | ||||
AT1 dividends paid | 28 | — | — | ( | — | — | — | ( |
Ordinary dividends paid | 10 | — | — | — | ( | — | — | ( |
Share premium | — | — | — | — | — | |||
Repurchase of own shares | — | — | — | — | ( | — | ( | |
Fair value of the cash settlement option on the growth shares | — | — | — | — | — | |||
Share-based payments | 35 | — | — | — | — | — | ||
Deferred tax on share based payments | 23 | — | — | — | — | — | ||
Current tax on share based payments | — | — | — | — | — | |||
Share settlement of share-based awards | — | — | — | ( | — | |||
Other movements | — | — | — | — | ( | |||
At 31 December 2024 | ( | ( |
2024 | 2023 | 2022 | ||||
Notes | $m | $m | $m | |||
Profit before tax | ||||||
Adjustments for: | ||||||
Amortisation of intangible assets | 12 | |||||
Loss on disposal of intangibles | 12 | |||||
Depreciation of property, plant and equipment | 13 | |||||
Depreciation of right-of-use asset | 30 | |||||
Impairment of right-of-use asset | 30 | |||||
Bargain purchase gain on acquisitions | 15 | ( | ( | |||
Impairment of goodwill | 11 | |||||
Movement in provisions | ( | |||||
Provision for credit losses | ( | |||||
Share of results in associates and joint ventures | ( | |||||
Lease liability foreign exchange revaluation | 30 | ( | ( | ( | ||
Movement in fair value of derivative instruments | ( | ( | ||||
Other revaluations | ( | |||||
Other non-cash movements | ( | |||||
Share-based payment expense | 35 | |||||
Operating cash flows before changes in working capital | 181.9 | |||||
Working capital adjustments: | ||||||
(Increase)/decrease in trade and other receivables | ( | |||||
Increase/(decrease) in trade and other payables | ( | ( | ||||
Increase in treasury instruments | ( | ( | ||||
Increase in fixed income securities | ( | ( | ( | |||
Increase in equity instruments | ( | ( | ( | |||
Increase in debt securities1 | ||||||
Decrease in financial institution notes | ||||||
Net increase/(repayment) of borrowings | ( | ( | ||||
Decrease/(increase) in inventory | ( | |||||
(Decrease)/increase in net repurchase and reverse repurchase agreements | ( | ( | ||||
Increase in net stock borrowing and lending | ||||||
Cash flow from operating activities | ||||||
Corporation tax paid | ( | ( | ( | |||
Net cash from operating activities |
2024 | 2023 | 2022 | ||||
Notes | $m | $m | $m | |||
Investing activities | ||||||
Redemption of investment in associate | ||||||
Acquisition of businesses, net of cash acquired | ( | ( | ( | |||
Payment of contingent consideration | ( | |||||
Purchase of investments | 14 | ( | ||||
Proceeds from sale of investments | 14 | |||||
Purchase of intangible assets | 12 | ( | ( | ( | ||
Purchase of property, plant and equipment | 13 | ( | ( | ( | ||
Net cash used in investing activities | ( | ( | ( | |||
Financing activities | ||||||
Proceeds from issuance of additional Tier 1 capital (AT1) | 28 | |||||
Issuance costs of additional Tier 1 capital (AT1) | 28 | ( | ||||
Repayment of Tier 2 debt securities | ( | |||||
Proceeds from issuance of ordinary shares | ||||||
Issuance costs of ordinary shares | ( | |||||
Purchase of own shares | 27 | ( | ( | ( | ||
Dividends paid | 10 | ( | ( | ( | ||
Lease incentive received | ||||||
Payment of lease liabilities | 30 | ( | ( | ( | ||
Net cash (used in)/from financing activities | ( | ( | ||||
Net increase in cash and cash equivalents | ||||||
Cash and cash equivalents | ||||||
Cash and cash equivalents at 1 January | ||||||
Increase in cash | ||||||
Effect of foreign exchange rate changes | ( | ( | ||||
Cash and cash equivalents at 31 December2 |
Clearing | Agency and Execution | Market Making | Hedging and Investment Solutions | Corporate | Total | ||||||
$m | $m | $m | $m | $m | $m | ||||||
Commission and fee income | |||||||||||
Commission and fee expense | ( | ( | ( | ( | |||||||
Net commission income/ (expense) | ( | ||||||||||
Net trading income | |||||||||||
Interest income/(expense) | ( | ||||||||||
Inter-segmental funding allocations1 | ( | ( | ( | ( | |||||||
Net interest income/(expense) | ( | ( | |||||||||
Net physical commodities income | |||||||||||
Revenue | |||||||||||
Adjusted profit/(loss) before tax | ( | ||||||||||
Other segment information | |||||||||||
Depreciation and amortisation | ( | ( | ( | ( | ( | ( | |||||
Compensation and benefits | ( | ( | ( | ( | ( | ( |
Clearing | Agency and Execution | Market Making | Hedging and Investment Solutions | Corporate | Total | ||||||
$m | $m | $m | $m | $m | $m | ||||||
Commission and fee income | |||||||||||
Commission and fee expense | ( | ( | ( | ( | |||||||
Net commission income/ (expense) | ( | ||||||||||
Net trading income/ (expense) | ( | ||||||||||
Interest income/(expense) | ( | ( | |||||||||
Inter-segmental funding allocations1 | ( | ( | ( | ( | |||||||
Net interest income/ (expense) | ( | ( | |||||||||
Net physical commodities income | |||||||||||
Revenue | |||||||||||
Adjusted profit/(loss) before tax | ( | ||||||||||
Other segment information | |||||||||||
Depreciation and amortisation | ( | ( | ( | ( | ( | ( | |||||
Compensation and benefits | ( | ( | ( | ( | ( | ( |
Clearing | Agency and Execution | Market Making | Hedging and Investment Solutions | Corporate | Total | ||||||
$m | $m | $m | $m | $m | $m | ||||||
Commission and fee income | |||||||||||
Commission and fee expense | ( | ( | ( | ( | |||||||
Net commission income/ (expense) | |||||||||||
Net trading income/(expense) | ( | ||||||||||
Interest income/(expense) | ( | ( | |||||||||
Intersegmental funding allocations | ( | ( | ( | ( | |||||||
Net interest income/ (expense) | ( | ( | |||||||||
Net physical commodities income | |||||||||||
Revenue | |||||||||||
Adjusted profit/(loss) before tax | ( | ||||||||||
Other segment information | |||||||||||
Depreciation and amortisation | ( | ( | ( | ( | ( | ( | |||||
Compensation and benefits | ( | ( | ( | ( | ( | ( |
2024 | 2023 | 2022 | |||
$m | $m | $m | |||
Total segments adjusted profit before tax | |||||
Goodwill impairment charge1 | ( | ( | |||
Bargain purchase gains2 | |||||
Acquisition costs3 | ( | ( | |||
Amortisation of acquired brands and customer lists4 | ( | ( | ( | ||
Activities relating to shareholders5 | ( | ( | ( | ||
Employer tax on vesting of the growth shares6 | ( | ||||
Owner fees7 | ( | ( | ( | ||
IPO preparation costs8 | ( | ( | ( | ||
Fair value of the cash settlement option on the growth shares9 | ( | ||||
Public offering of ordinary shares10 | ( | ||||
Profit before tax |
Revenue | Total Assets1 | |||||
2024 | 2023 | 2022 | 2024 | 2023 | ||
$m | $m | $m | $m | $m | ||
United Kingdom | ||||||
United States | ||||||
Rest of the world | ||||||
Total | ||||||
2024 | 2023 Restated1 | 2022 Restated1 | |||||||||
Amortise d Cost | FVTPL | Total | Amortise d Cost | FVTPL | Total | Amortise d Cost | FVTPL | Total | |||
$m | $m | $m | $m | $m | $m | $m | $m | $m | |||
Interest Income | |||||||||||
Financial institutions2 | |||||||||||
Exchanges | |||||||||||
Securities3 | |||||||||||
Clients4 | |||||||||||
Interest expense | |||||||||||
Clients5 | ( | ( | ( | ( | ( | ( | ( | ||||
Borrowings and debt issued6 | ( | ( | ( | ( | ( | ( | ( | ( | ( | ||
Exchanges7 | ( | ( | ( | ( | ( | ( | |||||
Securities8 | ( | ( | ( | ( | ( | ( | |||||
Lease interest expense | ( | ( | ( | ( | ( | ( | |||||
( | ( | ( | ( | ( | ( | ( | ( | ( | |||
Net interest income | ( | ( | ( | ||||||||
2024 | 2023 | 2022 | |||
$m | $m | $m | |||
Wages and salaries | |||||
Share-based compensation expense | |||||
Employer’s national insurance contributions and similar taxes | |||||
Short-term monetary benefits | |||||
Defined contribution pension cost | |||||
Apprenticeship levy | |||||
Redundancy payments | |||||
Total staff costs |
2024 | 2023 | 2022 | |||
$m | $m | $m | |||
Professional fees | |||||
Non-trading technology and support | |||||
Trading systems and market data | |||||
Occupancy and equipment rental | |||||
Travel and business development | |||||
Communications | |||||
Bank fees | |||||
Owner fees | |||||
VAT (irrecoverable) | |||||
Other | |||||
2024 | 2023 | 2022 | |||
$m | $m | $m | |||
Current tax | |||||
UK corporation tax on profit for the year | |||||
Foreign corporation tax on profit for the year | |||||
Total UK and Foreign corporation tax | |||||
Adjustment in respect of prior years: | |||||
UK corporation tax | |||||
Foreign corporation tax | ( | ( | |||
Total adjustments in respect of prior years | |||||
Deferred tax | |||||
Origination and reversal of temporary differences | ( | ( | ( | ||
Adjustment in respect of prior years – other | ( | ( | |||
( | ( | ( | |||
Tax expense for the year | |||||
Deferred tax charge relating to items recognised in OCI | |||||
Items that may be reclassified subsequently to profit and loss | ( | ||||
Items that will not be recycled to profit and loss | ( | ( | ( | ||
( | ( | ( | |||
Current tax expense relating to items recognised in Equity | ( | ||||
Deferred tax expense relating to items recognised in Equity | ( | ( |
2024 | 2023 | 2022 | |||
$m | $m | $m | |||
Profit before tax | |||||
Expected tax expense based on the standard rate of corporation tax in the UK of 25% (2023: 23.50%; 2022: 19.0%) | |||||
Explained by: | |||||
Effect of overseas tax rates | |||||
Income not subject to tax | ( | ( | ( | ||
Expenses not deductible for tax purposes | |||||
Non-deductible goodwill adjustments | ( | ||||
Movements in deferred tax not recognised | ( | ( | |||
Deductible payments on AT1 securities | ( | ( | ( | ||
Tax rate change | ( | ( | |||
Prior year adjustments | ( | ||||
Tax expense for the year |
2024 | ||
$m | ||
Ireland | ||
United Arab Emirates | ||
Total current tax expense related to Pillar II |
2024 | 2023 | ||
$m | $m | ||
Cost | |||
At 1 January | |||
Additions during the year | |||
Cost at 31 December | |||
Impairment losses at 1 January | ( | ( | |
Impairment of Volatility Performance Fund S.A. | ( | ||
Net book value at 31 December |
2024 | 2023 | ||
$m | $m | ||
Group goodwill by CGU: | |||
Energy | |||
CSC Commodities UK Limited | |||
Agriculture | |||
Volatility Performance Fund S.A. | |||
Rosenthal Collins Group | |||
Volcap Trading Partners Limited | |||
X-Change Financial Access LLC | |||
Recycled Metals | |||
ProTrader | |||
Marex Spectron Europe Limited | |||
Arfinco S.A. | |||
OTCex | |||
Cowen's Prime Services and Outsourced Trading Business1 | |||
Dropet | |||
I.L.S. Brokers Limited | |||
As at 31 December |
CGU | Pre-tax valuation discount rate | Breakeven discount rate | Valuation revenue growth rate | Breakeven revenue growth rate | Breakeven terminal value growth rate | Valuation cost growth rate | Breakeven cost growth rate | ||||||
Energy | ( | ( | |||||||||||
CSC Commodities UK Limited | ( | ( | |||||||||||
Agriculture | ( | n.m.1 | |||||||||||
Volatility Performance Fund S.A. | |||||||||||||
Rosenthal Collins Group | ( | ( | |||||||||||
Volcap Trading Partners Limited | |||||||||||||
X-Change Financial Access LLC | ( | ||||||||||||
Recycled Metals | ( | n.m.1 | |||||||||||
ProTrader | ( | n.m.1 | |||||||||||
Marex Spectron Europe Limited | ( | n.m.1 | |||||||||||
Arfinco S.A. | |||||||||||||
OTCex | ( | ( | |||||||||||
Cowen's Prime Services and Outsourced Trading Business |
CGU | Pre-tax valuation discount rate | Breakeven discount rate | Valuation revenue growth rate | Breakeven revenue growth rate | Breakeven terminal value growth rate | Valuation cost growth rate | Breakeven cost growth rate | ||||||
Energy | ( | ( | |||||||||||
CSC Commodities UK Limited | ( | ||||||||||||
Agriculture | ( | ( | |||||||||||
Volatility Performance Fund S.A. | ( | ||||||||||||
Rosenthal Collins Group | n.m.1 | n.m.1 | |||||||||||
Volcap Trading Partners Limited | ( | ( | |||||||||||
X-Change Financial Access LLC | ( | ( | |||||||||||
Recycled Metals | |||||||||||||
ProTrader | ( | n.m.1 | |||||||||||
Marex Spectron Europe Limited | ( | ||||||||||||
Arfinco S.A. | ( | ||||||||||||
OTCex SA Group | |||||||||||||
Cowen's Prime Services and Outsourced Trading Business | ( |
Customer Relationships1 | Brands | Software | Total | ||||
$m | $m | $m | $m | ||||
Cost | |||||||
At 1 January 2023 | |||||||
Additions on acquisitions | |||||||
Additions | |||||||
Disposals | ( | ( | |||||
At 31 December 2023 | |||||||
Additions on acquisitions | |||||||
Additions | |||||||
Disposals | ( | ( | |||||
At 31 December 2024 | |||||||
Impairment provisions and amortisation | |||||||
At 1 January 2023 | |||||||
Charge for the year | |||||||
Disposals | |||||||
At 31 December 2023 | 5.4 | 0.1 | 19.7 | ||||
Charge for the year | |||||||
Disposals | |||||||
At 31 December 2024 | |||||||
Net book value | |||||||
At 31 December 2024 | |||||||
At 31 December 2023 |
Pre-tax valuation discount rate | Breakeven discount rate | Valuation revenue growth rate | Breakeven revenue growth rate | Breakeven attrition rate | Valuation cost growth rate | Breakeven cost growth rate | |
Customer Relationships | ( |
Leasehold improvements | Computer equipment | Furniture, fixtures and fittings | Total | ||||
$m | $m | $m | $m | ||||
Cost | |||||||
At 1 January 2023 | |||||||
Additions on acquisitions | |||||||
Additions | |||||||
At 1 January 2024 | |||||||
Additions on acquisitions | |||||||
Additions | |||||||
Disposals | ( | ( | ( | ( | |||
At 31 December 2024 | |||||||
Depreciation | |||||||
At 1 January 2023 | |||||||
Charge for the year | |||||||
At 1 January 2024 | |||||||
Charge for the year | |||||||
Disposals | |||||||
At 31 December 2024 | |||||||
Net book value | |||||||
At 31 December 2024 | |||||||
At 31 December 2023 |
Leasehold improvements | over the remaining length of the lease or |
Computer equipment and other hardware | |
Furniture, fixtures and fittings |
2024 | 2023 | ||
$m | $m | ||
Cost | |||
At 1 January | |||
Additions | |||
Revaluation of investments held at FVTOCI | |||
Change in value of investments held at FVTPL | ( | ||
Disposals | ( | ||
At 31 December | |||
Listed investments | |||
Unlisted investments | |||
At 31 December |
$m | |
Cash consideration | |
Total consideration | |
Fair value of identifiable net assets: | |
Trade and other receivables | |
Intangible assets | |
Trade and other payables | ( |
Total fair value of identifiable assets and liabilities | |
Goodwill |
$m | |
Cash consideration | |
Total consideration | |
Fair value of identifiable net assets: | |
Intangible asset | |
Total fair value of identifiable assets and liabilities | |
Goodwill |
$m | |
Cash consideration | |
Total consideration | |
Fair value of identifiable net assets: | |
Intangible assets | |
Cash and cash equivalents | |
Trade and other receivables | |
Property, plant and equipment | |
Right of use asset | |
Lease Liability | ( |
Trade and other payables | ( |
Deferred tax liability | ( |
Total fair value of identifiable assets and liabilities | |
Goodwill |
FX rate | |||
$m | |||
Cash consideration (€ | |||
Contingent consideration | |||
Total consideration | |||
Fair value of identifiable net assets: | |||
Property, plant and equipment | |||
Intangible assets | |||
Right-of-use assets | |||
Cash and cash equivalents | |||
Trade and other receivables | |||
Trade and other payables | ( | ||
Lease liabilities | ( | ||
Taxes | ( | ||
Deferred tax liability | ( | ||
Total fair value of identifiable assets and liabilities | |||
Goodwill1 |
$m | |
Cash consideration | |
Total consideration | |
Fair value of identifiable net assets: | |
Cash and cash equivalents | |
Trade and other receivables | |
Intangible assets | |
Deferred tax liability | ( |
Trade and other payables | ( |
Total fair value of identifiable assets and liabilities | |
Goodwill |
$m | |
Cash consideration | |
Total consideration | |
Fair value of identifiable net assets: | |
Cash and cash equivalents | |
Trade and other receivables | |
Intangible assets | |
Trade and other payables | ( |
Deferred tax liability | ( |
Total fair value of identifiable assets and liabilities | |
Goodwill |
$m | |
Cash consideration | |
Total consideration | |
Fair value of identifiable net assets: | |
Intangible assets | |
Property, plant and equipment | |
Trade and other receivables | |
Derivative instruments – asset | |
Cash and cash equivalents | |
Trade and other payables | ( |
Derivative instruments – liability | ( |
Deferred tax liability | ( |
Total fair value of identifiable assets and liabilities | |
Goodwill1 |
$m | |
Cash consideration | |
Total consideration | |
Recognised amounts of identifiable net assets: | |
Cash and cash equivalents | |
Trade and other receivables | |
Right-of-use asset | |
Trade and other payables | ( |
Lease liabilities | ( |
Total fair value of identifiable assets and liabilities | |
Bargain purchase gain |
2024 | 2023 | ||
$m | $m | ||
Treasury instruments (pledged as collateral) - (non-current) | |||
Treasury instruments (pledged as collateral) - (current) | |||
2024 | 2023 | ||
$m | $m | ||
Treasury instruments (non-current) | |||
Treasury instruments (current) | |||
2024 | 2023 | ||
$m | $m | ||
Fixed income securities (current) |
2024 | 2023 | |||
$m | $m | $m | $m | |
Amortised Cost | Fair value through Profit or Loss2 | Amortised Cost (Restated1) | Fair value through Profit or Loss (Restated1) | |
Reverse repurchase agreements | ||||
Repurchase agreements | ( | ( | ||
( | ||||
2024 | 2023 | ||
$m | $m | ||
Cryptocurrency - Trading | |||
Carbon emission certificates and credits - Trading | |||
Recyclable scrap metals | |||
Total inventories at fair value less cost to sell |
Cost | Fair value movement | Inventory | |||
2024 | 2024 | 2024 | |||
$m | $m | $m | |||
Cryptocurrencies | ( | ||||
Carbon emission certificates and credits | |||||
Recyclable scrap metals | ( | ||||
( |
Cost | Fair value movement | Inventory | |||
2023 | 2023 | 2023 | |||
$m | $m | $m | |||
Cryptocurrencies | |||||
Carbon emission certificates and credits | ( | ||||
Recyclable scrap metals | |||||
2024 | 2023 | ||
$m | $m | ||
Amounts due from exchanges, clearing houses and other counterparties | |||
Amounts receivable from clients | |||
Trade debtors | |||
Default funds and deposits | |||
Loans receivable | |||
Other tax and social security taxes | |||
Other debtors | |||
Prepayments | |||
2024 | Current | Less than 30 days | 31 to 60 days | 61 to 90 days | 91 to 120 days | More than 120 days | Total |
Expected credit loss rate | |||||||
Trade debtors $m | |||||||
Trade debtors lifetime ECL $m |
2023 | Current | Less than 30 days | 31 to 60 days | 61 to 90 days | 91 to 120 days | More than 120 days | Total |
Expected credit loss rate | |||||||
Trade debtors $m | |||||||
Trade debtors lifetime ECL $m |
2024 ($m) | Current | Less than 30 days | 31 to 60 days | 61 to 90 days | 91 to 120 days | More than 120 days | Total |
Amounts due from exchanges, clearing houses and other counterparties | |||||||
Amounts receivable from clients | |||||||
Default funds and deposits | |||||||
Loans receivable | |||||||
Other debtors | |||||||
Corresponding allowance for loan losses ECL |
2023 ($m) | Current | Less than 30 days | 31 to 60 days | 61 to 90 days | 91 to 120 days | More than 120 days | Total |
Amounts due from exchanges, clearing houses and other counterparties | |||||||
Amounts receivable from clients | |||||||
Default funds and deposits | |||||||
Loans receivable | |||||||
Other debtors | |||||||
Corresponding allowance for loan losses ECL |
2024 | 2023 | ||
$m | $m | ||
At 1 January | |||
Bad debts written off | ( | ( | |
Released to the income statement | ( | ( | |
Charged to the income statement | |||
Other balance sheet movements | |||
At 31 December |
2024 | 2023 | ||
$m | $m | ||
Short-term borrowings | |||
Long-term borrowings | |||
Total borrowings |
2024 | 2023 | ||
$m | $m | ||
At 1 January | |||
Repayments | ( | ||
Additional draws | |||
Total borrowings | |||
2024 | 2023 | ||
Restated1 | |||
Financial assets | $m | $m | |
Held for trading derivatives carried at fair value through profit and loss that are not designated in hedge accounting relationships: | |||
Synthetic equity swap | |||
Agriculture contracts | |||
Energy contracts | |||
Foreign currency contracts | |||
Precious metal contracts | |||
Credit contracts | |||
Metals contracts | |||
Equity contracts | |||
Crypto contracts | |||
Rates contracts | |||
Held for trading derivatives that are designated in hedge accounting relationships: | |||
Foreign currency contracts | |||
Rates contracts | |||
2024 | 2023 | ||
Restated1 | |||
Financial liabilities | $m | $m | |
Held for trading derivatives carried at fair value through profit or loss that are not designated in hedge accounting relationships: | |||
Agriculture contracts | |||
Energy contracts | |||
Foreign currency contracts | |||
Precious metal contracts | |||
Credit contracts | |||
Metals contracts | |||
Equity contracts | |||
Crypto contracts | |||
Rates contracts | |||
Held for trading derivatives that are designated in hedge accounting relationships: | |||
Foreign currency contracts | |||
Rates contracts | |||
2024 | At 1 January | Credited/ (expensed) to the income statement | Recognised on acquisition | Credited to other comprehensive income & equity | At 31 December | ||||
$m | $m | $m | $m | $m | |||||
Acquired Intangibles | ( | ( | ( | ||||||
Compensation | |||||||||
Depreciation in excess of capital allowances | ( | ( | ( | ||||||
Lease accounting | |||||||||
Other short-term timing differences | ( | ||||||||
Prepayments | |||||||||
Revaluation of investments, cash flow hedges and liabilities designated at FVTPL | ( | ||||||||
Share-based payments | |||||||||
Tax losses | |||||||||
( |
2023 | At 1 January | Credited/ (expensed) to the income statement | Recognised on acquisition | Credited to other comprehensive income & equity | At 31 December |
$m | $m | $m | $m | $m | |
Acquired Intangibles | ( | ( | |||
Compensation | ( | ||||
Depreciation in excess of capital allowances | ( | ( | |||
Lease accounting | |||||
Other short-term timing differences | |||||
Prepayments | ( | ||||
Revaluation of investments, cash flow hedges and liabilities designated at FVTPL | ( | ( | |||
Share-based payments | ( | ||||
Tax losses | ( | ||||
( |
2024 | 2023 | |
$m | $m | |
Deferred tax asset | ||
Deferred tax liability | ( | ( |
31 December |
2024 | 2023 | ||
$m | $m | ||
Amounts due to exchanges, clearing houses and other counterparties | |||
Amounts payable to clients | |||
Accruals | |||
Trade payables | |||
Other tax and social security taxes | |||
Deferred income | |||
Other creditors | |||
Group | |||||||
Issued and fully paid | Issued and fully paid | ||||||
2024 | 2024 | 2023 | 2023 | ||||
Number | $'000 | Number | $'000 | ||||
Ordinary Shares of $ | |||||||
Ordinary Shares of $ | |||||||
Non-voting Ordinary Shares of $ | |||||||
Deferred Shares of $ | |||||||
Growth Shares of $ | |||||||
Group | |||||||||||
Ordinary shares of $ Number | Ordinary shares of $ Number | Non-voting Ordinary Shares of $ Number | Deferred Shares of £ Number | Growth Shares of $ Number | Total Number | ||||||
At 1 January 2024 | |||||||||||
Ordinary shares reorganisation pre-IPO (1) | ( | ( | ( | ||||||||
Total: Post ordinary shares organisation | |||||||||||
Reverse share split (2) | ( | ( | |||||||||
Deferred share cancellation (3) | ( | ( | |||||||||
Total: Post share capital organisation | |||||||||||
IPO | |||||||||||
At 31 December 2024 | |||||||||||
Group | |||||||||
Ordinary shares Number | Non-voting ordinary shares Number | Deferred shares Number | Growth shares Number | Total Number | |||||
At 1 January 2023 | |||||||||
Movement during the year | ( | ( | |||||||
At 31 December 2023 | |||||||||
Class of share | Rights |
Ordinary Shares | Full voting rights and right to participate in ordinary dividends ranking pari passu with non-voting ordinary shares. In the event of a winding up, entitled to a return of capital ranking pari passu with non-voting ordinary shares and no right of redemption. |
Non-voting Ordinary Shares | As per ordinary shares, other than having no voting rights. |
Deferred Shares | No voting rights, no right to participate in dividends or distributions and no right to redemption. On a return of capital on a winding up or otherwise, the assets of the Company available for distribution to its members shall be applied in paying a sum equal to £ shares pro rata according to the number of deferred shares held by them (rounded to the nearest £ all the holders shall in no event exceed £ |
Growth Shares | Following its initial public offering, the Company no longer has any growth shares. Growth shares were issued in several series as part of a share- based remuneration scheme. On a liquidity event such as an initial public offering or a sale, the growth shares entitled the holder thereof to a return should the proceeds exceed a specific level, as set for each series on issuance. The holders of growth shares had no voting rights, no rights to participate in dividends, no entitlements to participate in a winding up and could not impact the timing of a liquidity event. The growth shares were redeemable on a liquidity event in cash or by conversion into non-voting ordinary shares, as elected by the holders thereof. In the absence of such an election, the default settlement was conversion into non-voting ordinary shares. Prior to the initial public offering the holders of the growth shares elected to equity settle their awards. |
Reserves | Description |
Revaluation reserve | Cumulative unrealised gains on investments in exchanges that are held at FVTOCI and recognised in equity as well as changes in own credit risk. |
Cash flow hedge reserve | Cumulative unrealised gains and losses on hedging instruments deemed effective cash flow hedges. |
Currency translation reserve | On consolidation, the results of overseas operations are translated into USD at rates approximating to those prevailing when the transactions took place. All assets and liabilities of overseas operations, including goodwill arising on the acquisition of those operations, are translated at the rates ruling at the prevailing date. |
Right-of-use asset | |||
2024 | 2023 | ||
$m | $m | ||
As at 1 January | |||
Additions during the year | |||
Incentive of right-of-use asset | ( | ||
Adjustment to initial recognition of right of use asset | ( | ||
Depreciation charged to income statement | ( | ( | |
Impairment of right of use asset | ( | ( | |
As at 31 December | |||
Lease liability | |||
2024 | 2023 | ||
$m | $m | ||
As at 1 January | |||
Additions during the year | |||
Interest expense charged to income statement | |||
Payment of lease liabilities | ( | ( | |
Foreign exchange revaluation | ( | ( | |
Lease incentive | ( | ||
As at 31 December | |||
Lease Liability | |||
2024 | 2023 | ||
$m | $m | ||
Current liability | |||
Non-current liability | |||
As as 31 December | |||
Lease liability | |||
2024 | 2023 | ||
$m | $m | ||
1 year | |||
1 to 5 years | |||
More than 5 years | |||
Less: future interest expense | ( | ( | |
FVTPL | FVTOCI | Amortised cost | Total | ||||
2024 Financial assets | $m | $m | $m | $m | |||
Investments | |||||||
Treasury instruments2 | |||||||
Fixed income securities2 | |||||||
Equity instruments | |||||||
Derivative instruments3 | |||||||
Stock borrowing | |||||||
Reverse repurchase agreements | |||||||
Amounts due from exchanges, clearing houses and other counterparties | |||||||
Amounts receivable from clients | |||||||
Trade debtors | |||||||
Default funds and deposits | |||||||
Loans receivable | |||||||
Other debtors6 | |||||||
Cash and cash equivalents | |||||||
FVTPL | FVTOCI | Amortised cost | Total | ||||
2023 Financial assets (Restated)1 | $m | $m | $m | $m | |||
Investments | |||||||
Treasury instruments2 | |||||||
Fixed income securities2 | |||||||
Equity instruments | |||||||
Derivative instruments (Restated)1,3,4 | 3 | 4 | |||||
Stock borrowing (Restated)5 | |||||||
Reverse repurchase agreements (Restated)5 | |||||||
Amounts due from exchanges, clearing houses and other counterparties | |||||||
Amounts receivable from clients5 | |||||||
Trade debtors (Restated)5 | |||||||
Default funds and deposits | |||||||
Loans receivable | |||||||
Other debtors6 | |||||||
Cash and cash equivalents | |||||||
FVTPL | FVTOCI | Amortised cost | Total | ||||
2024 Financial liabilities | $m | $m | $m | $m | |||
Repurchase agreements | |||||||
Derivative instruments2 | |||||||
Short securities | |||||||
Amounts due to exchanges, clearing houses and other counterparties | |||||||
Amounts payable to clients | |||||||
Trade payables | |||||||
Other creditors | |||||||
Stock lending | |||||||
Short-term borrowings | |||||||
Debt securities3 | |||||||
Lease liability | |||||||
FVTPL | FVTOCI | Amortised cost | Total | ||||
2023 Financial liabilities (Restated)1 | $m | $m | $m | $m | |||
Repurchase agreements | |||||||
Derivative instruments (Restated)1 | |||||||
Short securities | |||||||
Amounts due to exchanges, clearing houses and other counterparties | |||||||
Amounts payable to clients | |||||||
Trade payables | |||||||
Other creditors | |||||||
Stock lending | |||||||
Debt securities3 | |||||||
Lease liability | |||||||
Gross amount | Amounts set-off | Net amount presented | Non-cash collateral rec’d/ (pledged) | Cash collateral rec’d/ (pledged) | Net amount | ||||||
2024 | $m | $m | $m | $m | $m | $m | |||||
Financial assets | |||||||||||
Amounts due from exchanges, clearing houses and other counterparties | ( | ||||||||||
Reverse repurchase agreements | ( | ( | |||||||||
Derivative instruments | ( | ( | |||||||||
Financial liabilities | |||||||||||
Amounts due to exchanges, clearing houses and other counterparties | ( | ||||||||||
Repurchase agreements | ( | ( | |||||||||
Derivative instruments | ( | ( | |||||||||
Gross amount | Amounts set-off | Net amount presented | Non-cash collateral rec’d/ (pledged) | Cash collateral rec’d/ (pledged) | Net amount | ||||||
2023 (Restated)1 | $m | $m | $m | $m | $m | $m | |||||
Financial assets | |||||||||||
Amounts due from exchanges, clearing houses and other counterparties | ( | ||||||||||
Reverse repurchase agreements | ( | ( | |||||||||
Derivative Instruments (Restated)1 | ( | ( | |||||||||
Financial liabilities | |||||||||||
Amounts due to exchanges, clearing houses and other counterparties | ( | ||||||||||
Repurchase agreements | ( | ( | |||||||||
Derivative Instruments (Restated)1 | ( | ( |
2024 | 2023 | ||
$m | $m | ||
AA and above | |||
AA- | |||
A+ | |||
A | |||
A- | |||
BBB+ | |||
Lower and unrated* | |||
2024 | |||||||
Average forward rates | Foreign currency | Notional value | Fair value assets | ||||
Outstanding contracts | ($/£) | $m | $m | $m | |||
Derivative assets designated as cash flow hedges | |||||||
Less than 3 months | |||||||
3 to 6 months | |||||||
6 to 12 months | |||||||
2024 | |||||||
Average forward rates | Foreign currency | Notional value | Fair value liabilities | ||||
Outstanding contracts | ($/£) | $m | $m | $m | |||
Derivative liabilities designated as cash flow hedges | |||||||
Less than 3 months | |||||||
3 to 6 months | |||||||
6 to 12 months | |||||||
2023 | |||||||
Average forward rates | Foreign currency | Notional value | Fair value assets | ||||
Outstanding contracts | ($/£) | $m | $m | $m | |||
Derivative assets designated as cash flow hedges | |||||||
Less than 3 months | |||||||
3 to 6 months | |||||||
6 to 12 months | |||||||
2023 | |||||||
Average forward rates | Foreign currency | Notional value | Fair value liabilities | ||||
Outstanding contracts | ($/£) | $m | $m | $m | |||
Derivative liabilities designated as cash flow hedges | |||||||
Less than 3 months | ( | ||||||
3 to 6 months | |||||||
6 to 12 months | ( | ||||||
( | |||||||
2024 | |||||
Outstanding contracts | Notional value $m | Net Amount Presented $m | |||
Derivative assets designated as cash flow hedges | |||||
Up to 6 months | |||||
6 to 12 months | |||||
1 to 5 years | |||||
2024 | |||||
Outstanding contracts | Notional value $m | Net Amount Presented $m | |||
Derivative liabilities designated as cash flow hedges | |||||
Up to 6 months | |||||
6 to 12 months | ( | ||||
1 to 5 years | ( | ||||
( | |||||
Notional Amount | Carrying Amount | Line item in the statement of financial position | Change in fair value used for recognising ineffectiveness for the year | ||||
$m | $m | $m | |||||
Interest rate swap | Derivative instruments | ( | |||||
Cross currency swap | ( | Derivative instruments | |||||
Fixed rate borrowing | Debt securities |
Notional Amount | Carrying Amount | Line item in the statement of financial position | Change in fair value used for recognising ineffectiveness for the year | ||||
$m | $m | $m | |||||
Interest rate swap | Derivative instruments | ||||||
Cross currency swap | Derivative instruments | — | |||||
Fixed rate borrowing | Debt securities | ( |
Secured borrowings and committed revolving credit facilities: | 2024 | 2023 | ||
$m | $m | |||
Amount used | 21(a) | |||
Amount unused | 21(c) | |||
On demand | Less than 3 months | 3 to 12 months | 1 to 5 years | More than 5 years | Total | ||||||
2024 | $m | $m | $m | $m | $m | $m | |||||
Repurchase agreements | |||||||||||
Short securities | |||||||||||
Amounts due to exchanges, clearing houses and other counterparties | |||||||||||
Amounts payable to clients | |||||||||||
Trade payables | |||||||||||
Other creditors | |||||||||||
Stock lending | |||||||||||
Short term borrowings | |||||||||||
Debt securities | |||||||||||
Lease liabilities | |||||||||||
On demand | Less than 3 months | 3 to 12 months | 1 to 5 years | More than 5 years | Total | ||||||
2023 | $m | $m | $m | $m | $m | $m | |||||
Repurchase agreements | |||||||||||
Short securities | |||||||||||
Amounts due to exchanges, clearing houses and other counterparties | |||||||||||
Amounts payable to clients | |||||||||||
Trade payables | |||||||||||
Other creditors | |||||||||||
Stock lending | |||||||||||
Debt securities | |||||||||||
Lease liabilities | |||||||||||
2024 | On demand $m | Less than 3 months $m | 3 to 12 months $m | 1 to 5 years $m | More than 5 years $m | Total $m | |||||
Treasury instruments | |||||||||||
Fixed income securities | |||||||||||
Equity instruments | |||||||||||
Stock borrowing | |||||||||||
Reverse repurchase agreements | |||||||||||
Amounts due from exchanges, clearing houses and other counterparties | |||||||||||
Amounts receivable from clients | |||||||||||
Trade debtors | |||||||||||
Default funds and deposits | |||||||||||
Loans receivable | |||||||||||
Other debtors | |||||||||||
Cash and cash equivalents | |||||||||||
2023 | On demand $m | Less than 3 months $m | 3 to 12 months $m | 1 to 5 years $m | More than 5 years $m | Total $m | |||||
Treasury instruments | |||||||||||
Fixed income securities | |||||||||||
Equity instruments | |||||||||||
Stock borrowing | |||||||||||
Reverse repurchase agreements | |||||||||||
Amounts due from exchanges, clearing houses and other counterparties | |||||||||||
Amounts receivable from clients | |||||||||||
Trade debtors | |||||||||||
Default funds and deposits | |||||||||||
Loans receivable | |||||||||||
Other debtors | |||||||||||
Cash and cash equivalents | |||||||||||
2024 | On demand | Less than 3 months | 3 to 12 months | 1 to 5 years | 5 + years | Total | |||||
Derivative instruments | $m | $m | $m | $m | $m | $m | |||||
Assets | |||||||||||
Liabilities | ( | ( | ( | ( | ( | ||||||
( |
2023 (Restated)1 | On demand | Less than 3 months | 3 to 12 months | 1 to 5 years | 5 + years | Total | |||||
Derivative instruments | $m | $m | $m | $m | $m | $m | |||||
Assets | |||||||||||
Liabilities | ( | ( | ( | ( | ( | ||||||
Level 1 | Level 2 | Level 3 | Total | ||||
2024 | $m | $m | $m | $m | |||
Financial assets – FVTPL: | |||||||
Equity instruments | |||||||
Treasury Instruments | |||||||
Fixed income securities | |||||||
Derivative instruments | |||||||
Amounts receivable from clients | |||||||
Trade debtors | |||||||
Reverse repurchase agreements | |||||||
Stock borrowing | |||||||
Financial assets – FVTOCI: | |||||||
Investments | |||||||
Derivative instruments | |||||||
Financial liabilities – FVTOCI: | |||||||
Derivative instruments | ( | ( | |||||
Financial liabilities – FVTPL: | |||||||
Derivative instruments | ( | ( | ( | ||||
Trade payables | ( | ( | |||||
Amounts payable to clients | ( | ( | |||||
Short securities | ( | ( | ( | ||||
Debt securities | ( | ( | ( | ||||
Stock lending | ( | ( | |||||
Repurchase agreements | ( | ( | |||||
( | ( |
Level 1 | Level 2 | Level 3 | Total | ||||
2023 (Restated)1 | $m | $m | $m | $m | |||
Financial assets – FVTPL: | |||||||
Equity instruments | |||||||
Derivative instruments (Restated)1 | |||||||
Trade debtors (Restated)2 | |||||||
Stock borrowing (Restated)2 | |||||||
Reverse repurchase agreements (Restated)2 | |||||||
Amounts receivable from clients2 | |||||||
Fixed income securities | |||||||
Financial assets – FVTOCI: | |||||||
Investments | |||||||
Derivative instruments | |||||||
Financial liabilities – FVTOCI: | |||||||
Derivative instruments | ( | ( | |||||
Financial liabilities – FVTPL: | |||||||
Derivative instruments (Restated)1 | ( | ( | ( | ( | |||
Trade payables | ( | ( | |||||
Amounts payable to clients | ( | ( | |||||
Short securities | ( | ( | |||||
Debt securities | ( | ( | ( | ||||
( |
2024 | 2023 | ||
$m | $m | ||
Balance at 1 January | |||
Purchases | |||
Settlements | ( | ( | |
Total gains or losses in the period recognised in the income statement: | |||
Market Making revenue | |||
Transfers out of Level 3 | ( | ||
Transfers into Level 3 | |||
Balance at 31 December |
2024 | 2023 | ||
$m | $m | ||
Balance at 1 January | |||
Purchases | |||
Settlements | ( | ( | |
Total gains or losses in the period recognised in the income statement: | |||
Market Making revenue | ( | ||
Transfers out of Level 3 | ( | ( | |
Transfers into Level 3 | |||
Balance at 31 December |
2024 | 2023 | ||
$m | $m | ||
Segregated assets at banks (not recognised) | |||
Segregated assets at exchanges, clearing houses and other counterparties (not recognised) | |||
Segregated assets at exchanges, clearing houses and other counterparties (recognised) | |||
2024 | 2023 | 2022 | |||
Restated1 | Restated1 | ||||
Profit before tax ($m) | |||||
Tax ($m) | ( | ( | ( | ||
Profit after tax ($m) | |||||
AT1 dividends paid ($m) | ( | - | ( | ||
Profit attributable to ordinary shareholders of the Group ($m) | |||||
Weighted average number of ordinary shares during the year | |||||
Basic earnings per share ($) | |||||
Weighted average number of ordinary shares for basic EPS | |||||
Effect of dilution from: | |||||
Share schemes | |||||
Weighted average number of ordinary shares adjusted for the effect of dilution | |||||
Diluted earnings per share ($) |
2024 | 2023 | 2022 | |||
$m | $m | $m | |||
Aggregate wages and salaries | |||||
Short-term monetary benefits | |||||
Defined contribution pension cost | |||||
Management Incentive plan | |||||
2024 | 2023 | ||
$m | $m | ||
Deferred Bonus Plan | |||
Retention Long Term Incentive Plan | |||
Annual Long Term Incentive Plan | |||
All Employee Plan | |||
Non-Executive Directors' Plan | |||
Total equity-settled share-based payments |
2024 | 2023 | ||
Number | Number | ||
Outstanding at the beginning of the year | |||
Reverse Share Split | ( | ||
Granted during the year | |||
Vested during the year | ( | ( | |
Forfeited during the year | ( | ||
Outstanding at the end of the year | |||
Weighted average fair value of awards granted ($) |
As reported | Adjustment | As restated | |
31 December 2023 | $m | $m | $m |
Derivative instruments - assets | ( | ||
Total current assets | ( | ||
Total assets | ( | ||
Derivative instruments - liabilities | ( |
Total current liabilities | ( | ||
Total liabilities | ( |
2024 | 2023 | 2022 | |||
$m | $m | $m | |||
Interest income | |||||
Interest expense | ( | ( | ( | ||
Net interest income | |||||
Dividend income | |||||
Expenses: | |||||
Impairment of investments in subsidiaries | ( | ( | ( | ||
Other income | |||||
Other expenses | ( | ( | ( | ||
(Loss)/profit before tax | ( | ( | |||
Tax | ( | ( | ( | ||
(Loss)/profit after tax | ( | ( | |||
Other comprehensive loss | ( | ( | ( | ||
Total comprehensive (loss)/income | ( | ( |
2024 | 2023 | ||||
$m | $m | ||||
Assets | |||||
Non-current assets | |||||
Investments | |||||
Investments in subsidiaries | |||||
Deferred tax | |||||
Subordinated loans due from group undertakings | |||||
Total non-current assets | |||||
Current assets | |||||
Trade and other receivables | |||||
Derivative instruments | |||||
Cash and cash equivalents | |||||
Total current assets | |||||
Total assets | |||||
Liabilities | |||||
Current liabilities | |||||
Trade and other payables | |||||
Derivative instruments | |||||
Corporation tax | |||||
Debt securities | |||||
Total current liabilities | |||||
Non-current liabilities | |||||
Debt securities | |||||
Total non-current liabilities | |||||
Total liabilities | |||||
Total net assets | |||||
Equity | |||||
Share capital | |||||
Share premium | |||||
Additional Tier 1 capital (AT1) | |||||
Retained earnings | |||||
Own shares | ( | ( | |||
Other reserve | ( | ( | |||
Total equity |
2024 | 2023 | 2022 | ||||
$m | $m | $m | ||||
(Loss)/profit before tax | ( | ( | ||||
Adjustments to reconcile (loss)/profit before tax to net cash flows: | ||||||
Impairment of investments in subsidiaries | ||||||
Bargain purchase gain on acquisitions | ( | |||||
Movement in fair value of derivative instruments | ( | |||||
Share-based payment expense | ||||||
Other revaluations | ( | |||||
Operating cash flows before changes in working capital | ||||||
Working capital adjustments: | ||||||
Increase in trade and other receivables | ( | ( | ||||
Increase/(decrease) in trade and other payables | ( | |||||
Increase in equity instruments | ( | ( | ( | |||
Increase in debt securities | ||||||
Cash inflow/(outflow) from operating activities | ( | |||||
Corporation tax paid | ( | ( | ( | |||
Net cash inflow/(outflow) from operating activities | ( | |||||
Investing activities | ||||||
(Increase)/decrease in subordinated loan receivable | ( | ( | ||||
Net cash (outflow)/inflow from investing activities | ( | ( | ||||
Financing activities | ||||||
Proceeds from issuance of Additional Tier 1 capital (AT1) | ||||||
Issuance costs of Additional Tier 1 capital (AT1) | ( | |||||
Repayment of Tier 2 debt securities | ( | |||||
Proceeds from issuance of ordinary shares | ||||||
Issuance costs of ordinary shares | ( | |||||
Purchase of own shares | ( | ( | ( | |||
Dividends paid | ( | ( | ( | |||
Net cash outflow from financing activities | ( | ( | ||||
Net increase in cash and cash equivalents | ||||||
Cash and cash equivalents | ||||||
Cash at banks and on hand and short-term deposits at 1 January | ||||||
Increase in cash | ||||||
Cash and cash equivalents at 31 December |
